SGHT
Sight Sciences, Inc.NASDAQHealthcare$3.52-3.83%ClosedMarket Cap: $190.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.95
P/S
2.48
EV/EBITDA
-3.84
DCF Value
$1.18
FCF Yield
-15.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.2%
Operating Margin
-48.0%
Net Margin
-49.7%
ROE
-55.7%
ROA
-33.3%
ROIC
-35.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $20.4M | 87.3% | $-3.7M | $-4.2M | $-0.08 | — |
| FY 2025 | $77.4M | 86.2% | $-37.1M | $-38.4M | $-0.74 | — |
| Q3 2025 | $19.9M | 86.4% | $-7.9M | $-8.2M | $-0.16 | — |
| Q2 2025 | $19.6M | 84.8% | $-11.7M | $-11.9M | $-0.23 | — |
| Q1 2025 | $17.5M | 86.2% | $-13.9M | $-14.2M | $-0.28 | — |
| Q4 2024 | $19.1M | 86.8% | $-11.9M | $-11.8M | $-0.23 | — |
| FY 2024 | $79.9M | 85.5% | $-50.5M | $-51.5M | $-1.03 | — |
| Q3 2024 | $20.2M | 83.9% | $-11.2M | $-11.1M | $-0.22 | — |
| Q2 2024 | $21.4M | 85.8% | $-12.7M | $-12.3M | $-0.25 | — |
| Q1 2024 | $19.3M | 85.5% | $-14.7M | $-16.3M | $-0.33 | — |
| Q4 2023 | $18.8M | 85.2% | $-11.1M | $-10.7M | $-0.22 | — |
| FY 2023 | $81.1M | 85.3% | $-57.3M | $-55.5M | $-1.14 | — |